Nuvexa
- Product NDC
- 85477-313
- 11-digit product format
- 854770313
- Labeler code
- 85477
- Product ID
- 85477-313_88871176-4334-49fb-a1e9-a700910dc570
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lidocaine 2.8
- Dosage form
- GEL
- Route
- TOPICAL
- Labeler
- Oncora Pharma, LLC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2026-10-22
- Substance
- LIDOCAINE
- Active strength
- 28 mg/g
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Nuvexa
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LIDOCAINE | 28 mg/g |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 85477-313-07 | 85477031307 | 100 g in 1 BOTTLE, PUMP (85477-313-07) | 100 g | 2026-10-22 | No | No | Current |